Paroxysmal Supraventricular Tachycardia Following Ondansentron Intravenous Administration: A Case Report
Ondasentron is selective serotonin 5-HT3 receptor antagonist. It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery. This drug become more popular because its superior efficacy and minimal side effect. Although cardiovascular advers...
Main Author: | Erick Hoetama |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2015-12-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/439 |
Similar Items
-
Maternal Death Following Medical Treatment of Paroxysmal Supraventricular Tachycardia in Late Gestation
by: Ping-Hung Kuo, et al.
Published: (2005-09-01) -
Twelve‐lead electrocardiography identifies the therapeutic target of paroxysmal supraventricular tachycardia
by: Keiji Matsunaga, et al.
Published: (2020-02-01) -
Paroxysmal supraventricular tachycardia and risk of ischemic stroke: A systematic review and meta‐analysis
by: Pongprueth Rujirachun, et al.
Published: (2019-06-01) -
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia
by: N M Nazhalkina, et al.
Published: (2017-12-01) -
Regulatory adaptive status in determining the effectiveness of nebivololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia
by: Nazhalkina N.M., et al.
Published: (2017-11-01)